Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.
Sep 26, 2023
Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles
Sangine will collect concentrated white blood cell biospecimens through apheresis from participants in Sanguine’s Southern California Patient Community…
Sep 13, 2023
Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Trans...
Apr 16, 2021
PODCAST: The Bio Report: Bringing the Trial to the Patient
Apr 04, 2021
Recovered Coronavirus Patient Donates Blood To Help Vaccine, Treatment Research
Aug 03, 2020
Sanguine Bio Accelerates Pace in Vaccine Race
Jun 29, 2020
Overcoming Study-Patient Burdens in Medical Research During the Pandemic
Jun 21, 2020
Recovered Patients Help Sanguine BioSciences Advance COVID-19 Medical Research
